Seminars in Arthritis and Rheumatism
Volume 39, Issue 4 , Pages 257-268 , February 2010

Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus

  • Guillermo J. Pons-Estel, MD

      Affiliations

    • Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL
    • ,
  • Graciela S. Alarcón, MD, MPH

      Affiliations

    • Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL
    • ,
  • Lacie Scofield, MSPH

      Affiliations

    • Office of Women's Health, U.S. Department of Health and Human Services, Washington, DC
    • National Institute of Environmental Health Sciences, Research Triangle Park, NC
    • ,
  • Leslie Reinlib, PhD

      Affiliations

    • National Institute of Environmental Health Sciences, Research Triangle Park, NC
    • ,
  • Glinda S. Cooper, PhD

      Affiliations

    • National Institute of Environmental Health Sciences, Research Triangle Park, NC
    • Office of Research and Development, National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC
    • Corresponding Author InformationAddress reprint requests to Glinda S. Cooper, PhD, National Center for Environmental Assessment (8601-P), U.S. Environmental Protection Agency, 1200 Pennsylvania Avenue, NW, Washington, DC 20460

References 

  1. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol. 2001;13:345–351
  2. Alarcón GS. Of ethnicity, race and lupus. Lupus. 2001;10:594–596
  3. Huth EJ. Identifying ethnicity in medical papers. Ann Intern Med. 1995;122:619–621
  4. Senior PA, Bhopal R. Ethnicity as a variable in epidemiological research. BMJ. 1994;309:327–330
  5. Fernandez M, Alarcón GS, Calvo-Alen J, Andrade R, McGwin G, Vila LM, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007;57:576–584
  6. Uramoto KM, Michet CJ, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999;42:46–50
  7. McCarty DJ, Manzi S, Medsger TA, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus (Race and gender differences). Arthritis Rheum. 1995;38:1260–1270
  8. Naleway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus. 2005;14:862–866
  9. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol. 2000;27:1884–1891
  10. Nossent JC. Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation. Ann Rheum Dis. 1992;51:1197–1201
  11. Vilar MJ, Sato EI. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus. 2002;11:528–532
  12. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000;27:685–691
  13. Jonsson H, Nived O, Sturfelt G, Silman A. Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol. 1990;29:185–188
  14. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol. 1998;27:98–105
  15. Nossent HC. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol. 2001;28:539–546
  16. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England (Relationship to ethnicity and country of birth). Arthritis Rheum. 1995;38:551–558
  17. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol. 1993;32:110–115
  18. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis. 1994;53:675–680
  19. Nightingale AL, Farmer RD, de Vries CS. Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf. 2006;15:656–661
  20. Somers EC, Thomas SL, Smeeth L, Schoonen WM, Hall AJ. Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. Arthritis Rheum. 2007;57:612–618
  21. Gudmundsson S, Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984 (A nationwide epidemiological study in an unselected population). J Rheumatol. 1990;17:1162–1167
  22. Lopez P, Mozo L, Gutierrez C, Suarez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus. 2003;12:860–865
  23. Alamanos Y, Voulgari PV, Siozos C, Katsimpri P, Tsintzos S, Dimou G, et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J Rheumatol. 2003;30:731–735
  24. Anstey NM, Bastian I, Dunckley H, Currie BJ. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Aust NZ J Med. 1993;23:646–651
  25. Maskarinec G, Katz AR. Prevalence of systemic lupus erythematosus in Hawaii: is there a difference between ethnic groups?. Hawaii Med J. 1995;54:406–409
  26. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007;56:2092–2094
  27. Boyer GS, Templin DW, Lanier AP. Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 1991;18:1477–1484
  28. Hochberg MC. Prevalence of systemic lupus erythematosus in England and Wales, 1981-2. Ann Rheum Dis. 1987;46:664–666
  29. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis. 1991;50:490–492
  30. Molokhia M, McKeigue P. Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res. 2000;2:115–125
  31. Gourley IS, Patterson CC, Bell AL. The prevalence of systemic lupus erythematosus in Northern Ireland. Lupus. 1997;6:399–403
  32. Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, Al-Saleh SS, Bahabri SA, Mousa MM, et al. Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J. 2002;23:87–89
  33. Bossingham D. Systemic lupus erythematosus in the far north of Queensland. Lupus. 2003;12:327–331
  34. Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus. 2001;10:439–444
  35. Hart HH, Grigor RR, Caughey DE. Ethnic difference in the prevalence of systemic lupus erythematosus. Ann Rheum Dis. 1983;42:529–532
  36. Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman L, et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis. 1971;21:643–648
  37. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277
  38. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725
  39. Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B, et al. Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus. 1995;4:454–456
  40. Ward MM. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health (Larchmt). 2004;13:713–718
  41. Johnson AE, Gordon C, Hobbs FD, Bacon PA. Undiagnosed systemic lupus erythematosus in the community. Lancet. 1996;347:367–369
  42. Bae SC, Fraser P, Liang MH. The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the “prevalence gradient hypothesis”. Arthritis Rheum. 1998;41:2091–2099
  43. Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum. 1985;28:80–86
  44. Huemer C, Huemer M, Dorner T, Falger J, Schacherl H, Bernecker M, et al. Incidence of pediatric rheumatic diseases in a regional population in Austria. J Rheumatol. 2001;28:2116–2119
  45. Huang JL, Yao TC, See LC. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol. 2004;22:776–780
  46. Alarcón GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III (A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs Nurture). Lupus. 1999;8:197–209
  47. Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore). 2004;83:1–17
  48. Merrell M, Shulman LE. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis. 1955;1:12–32
  49. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991;21:55–64
  50. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore). 2006;85:147–156
  51. Alarcón GS, McGwin G, Bastian HM, Roseman J, Lisse J, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups (VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group). Arthritis Rheum. 2001;45:191–202
  52. Campbell R, Cooper GS, Gilkeson GS. Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: mortality risk and quality of life early in the course of disease. Arthritis Rheum. 2008;59:458–464
  53. Alamanos Y, Voulgari PV, Papassava M, Tsamandouraki K, Drosos AA. Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece (Study of a 21-year incidence cohort). Rheumatology (Oxford). 2003;42:1122–1123
  54. Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002;61:1065–1070
  55. Wang LC, Yang YH, Lu MY, Chiang BL. Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect. 2003;36:203–208
  56. Mok CC, Lee KW, Ho CT, Lau CS, Wong RW. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford). 2000;39:399–406
  57. Kasitanon N, Louthrenoo W, Sukitawut W, Vichainun R. Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2002;20:85–91
  58. Murali R, Jeyaseelan L, Rajaratnam S, John L, Ganesh A. Systemic lupus erythematosus in Indian patients: prognosis, survival and life expectancy. Natl Med J India. 1997;10:159–164
  59. Hochberg MC. Mortality from systemic lupus erythematosus in England and Wales, 1974-1983. Br J Rheumatol. 1987;26:437–441
  60. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976;60:221–225
  61. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus (Results from a single center. III. Improved survival over 24 years). J Rheumatol. 1997;24:1061–1065
  62. Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. J Rheumatol. 2004;31:713–719
  63. Abu-Shakra M, Gladman DD, Urowitz MB. Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev. 2004;3:418–420
  64. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002;61:409–413
  65. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, et al. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol. 1999;28:75–80
  66. Bellomio V, Spindler A, Lucero E, Berman A, Santana M, Moreno C, et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus. 2000;9:377–381
  67. Swaak AJ, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L, et al. Systemic lupus erythematosus (I. Outcome and survival: Dutch experience with 110 patients studied prospectively). Ann Rheum Dis. 1989;48:447–454
  68. Blanco FJ, Gomez-Reino JJ, de la Mata J, Corrales A, Rodriguez-Valverde V, Rosas JC, et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus. 1998;7:159–163
  69. Ward MM, Studenski S. Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations. J Rheumatol. 1990;17:220–224
  70. Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus (Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death). Arthritis Rheum. 1990;33:37–48
  71. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus (Patient characteristics associated with poorer outcomes). Arthritis Rheum. 1995;38:274–283
  72. Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, et al. A multicenter study of outcome in systemic lupus erythematosus (I. Entry variables as predictors of prognosis). Arthritis Rheum. 1982;25:601–611
  73. Trends in deaths from systemic lupus erythematosus—United States, 1979-1998. MMWR Morb Mortal Wkly Rep. 2002;51:371–374
  74. Duran S, Apte M, Alarcón GS. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc. 2007;99:1196–1198
  75. Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Cohen PL, et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus. 2002;11:161–167
  76. Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, et al. Systemic lupus erythematosus in males (A study of 107 Latin American patients). Medicine (Baltimore). 1996;75:124–130
  77. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period (A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus). Medicine (Baltimore). 1999;78:167–175
  78. Andrade RM, Alarcón GS, Fernandez M, Apte M, Vila LM, Reveille JD. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV (Results from a multiethnic US cohort). Arthritis Rheum. 2007;56:622–630
  79. Garcia MA, Marcos JC, Marcos AI, Pons-Estel BA, Wojdyla D, Arturi A, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus. 2005;14:938–946
  80. Alarcón GS, Calvo-Alen J, McGwin G, Uribe AG, Toloza SM, Roseman J, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006;65:1168–1174
  81. Alarcón GS, Roseman J, Bartolucci AA, Friedman AW, Moulds JM, Goel N, et al. Systemic lupus erythematosus in three ethnic groups: II (Features predictive of disease activity early in its course. LUMINA Study Group Lupus in minority populations, nature versus nurture). Arthritis Rheum. 1998;41:1173–1180
  82. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus (Identification of racial and socioeconomic influences). Arch Intern Med. 1990;150:849–853
  83. Alarcón GS, McGwin G, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus. 2002;11:95–101
  84. Bastian HM, Roseman JM, McGwin G, Alarcón GS, Friedman AW, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups (XII. Risk factors for lupus nephritis after diagnosis). Lupus. 2002;11:152–160
  85. Alarcón GS, McGwin G, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups (IX. Differences in damage accrual). Arthritis Rheum. 2001;44:2797–2806
  86. Toloza SM, Uribe AG, McGwin G, Alarcón GS, Fessler BJ, Bastian HM, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) (XXIII. Baseline predictors of vascular events). Arthritis Rheum. 2004;50:3947–3957
  87. Rivest C, Lew RA, Welsing PM, Sangha O, Wright EA, Roberts WN, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol. 2000;27:680–684
  88. Cooper GS, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum. 2007;57:993–999
  89. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998;57:456–459
  90. Bakr A. Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt. Pediatr Nephrol. 2005;20:1081–1086
  91. Lehman TJ, McCurdy DK, Bernstein BH, King KK, Hanson V. Systemic lupus erythematosus in the first decade of life. Pediatrics. 1989;83:235–239
  92. Carreno L, Lopez-Longo FJ, Monteagudo I, Rodriguez-Mahou M, Bascones M, Gonzalez CM, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus. 1999;8:287–292
  93. Sibbitt WL, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29:1536–1542
  94. Quintero-Del-Rio AI, Van M. Neurologic symptoms in children with systemic lupus erythematosus. J Child Neurol. 2000;15:803–807
  95. Mak SK, Lam EK, Wong AK. Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus. 1998;7:23–28
  96. Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus. 2000;9:96–100
  97. Ho CT, Mok CC, Lau CS, Wong RW. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis. 1998;57:437–440
  98. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI (SLE Disease Activity Index). Lupus. 1999;8:462–465
  99. Ward MM, Polisson RP. A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum. 1989;32:1226–1232
  100. Maddison P, Farewell V, Isenberg D, Aranow C, Bae SC, Barr S, et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol. 2002;29:913–917
  101. Costallat LT, Coimbra AM. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol. 1994;12:603–607
  102. Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004;83:348–359
  103. Bertoli AM, Alarcón GS, Calvo-Alen J, Fernandez M, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease). Arthritis Rheum. 2006;54:1580–1587
  104. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989;32:1107–1118
  105. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:809–813
  106. Alarcón GS, McGwin G, Brooks K, Roseman JM, Fessler BJ, Sanchez ML, et al. Systemic lupus erythematosus in three ethnic groups (XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores). Arthritis Rheum. 2002;47:408–413
  107. Yen JC, Neville C, Fortin PR. Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials. Lupus. 1999;8:660–670
  108. Yen JC, Abrahamowicz M, Dobkin PL, Clarke AE, Battista RN, Fortin PR. Determinants of discordance between patients and physicians in their assessment of lupus disease activity. J Rheumatol. 2003;30:1967–1976
  109. Ferraz LB, de Almeida FA, Vasconcellos MR, Ferraz MB. Alopecia impairs the quality of life of patients with lupus erythematosus. Arch Dermatol. 2006;142:110
  110. Alarcón GS, McGwin G, Sanchez ML, Bastian HM, Fessler BJ, Friedman AW, et al. Systemic lupus erythematosus in three ethnic groups (XIV. Poverty, wealth, and their influence on disease activity). Arthritis Rheum. 2004;51:73–77
  111. Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005;32:1699–1705
  112. Kozora E, Ellison MC, Waxmonsky JA, Wamboldt FS, Patterson TL. Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus. Lupus. 2005;14:363–372
  113. McCracken LM, Semenchuk EM, Goetsch VL. Cross-sectional and longitudinal analyses of coping responses and health status in persons with systemic lupus erythematosus. Behav Med. 1995;20:179–187
  114. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fossel AH, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:47–56
  115. Lett HS, Blumenthal JA, Babyak MA, Catellier DJ, Carney RM, Berkman LF, et al. Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol. 2007;26:418–427
  116. Shah S, Cook DG. Inequalities in the treatment and control of hypertension: age, social isolation and lifestyle are more important than economic circumstances. J Hypertens. 2001;19:1333–1340
  117. Penninx BW, van Tilburg T, Boeke AJ, Deeg DJ, Kriegsman DM, van Eijk JT. Effects of social support and personal coping resources on depressive symptoms: different for various chronic diseases?. Health Psychol. 1998;17:551–558
  118. Lee SJ, Detels R, Rotheram-Borus MJ, Duan N, Lord L. Depression and social support among HIV-affected adolescents. AIDS Patient Care STDS. 2007;21:409–417
  119. Karlson EW, Liang MH, Eaton H, Huang J, Fitzgerald L, Rogers MP, et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum. 2004;50:1832–1841
  120. Alarcón GS, Rodriguez JL, Benavides G, Brooks K, Kurusz H, Reveille JD. Systemic lupus erythematosus in three ethnic groups (V. Acculturation, health-related attitudes and behaviors, and disease activity in Hispanic patients from the LUMINA cohort LUMINA Study Group Lupus in Minority Populations, Nature versus Nurture). Arthritis Care Res. 1999;12:267–276
  121. Sanchez ML, Bastian HM, Fessler BJ, Reveille JD, Vila LM, Alarcón GS. Perception of discrimination oin SLE patients from a multiethnic cohort. Arthritis Rheum. 2004;2004:S241
  122. McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts (Results from the Medical Outcomes Study). Med Care. 1992;30:MS253–MS265
  123. Alarcón GS, McGwin G, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA) (XVII. Predictors of self-reported health-related quality of life early in the disease course). Arthritis Rheum. 2004;51:465–474
  124. Rinaldi S, Doria A, Salaffi F, Ermani M, Iaccarino L, Ghirardello A, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus (I. Relationship between physical and mental dimension and impact of age). Rheumatology (Oxford). 2004;43:1574–1579
  125. Thumboo J, Chan SP, Machin D, Soh CH, Feng PH, Boey ML, et al. Measuring health-related quality of life in Singapore: normal values for the English and Chinese SF-36 Health Survey. Ann Acad Med Singapore. 2002;31:366–374
  126. Thumboo J, Fong KY, Ng TP, Leong KH, Feng PH, Thio ST, et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol. 1999;26:97–102
  127. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13:873–884
  128. Ware JE, Kosinsk M, Dewey JE, Gandek B. How to score and interpret single-item health status measures: a manual for users of the SF-8TM Health Survey. Lincoln, RI: QualityMetric Incorporated; 2001;
  129. Sanchez ML, McGwin G, Duran S, Fernandez M, Apte M, Vila LM, et al. Factors associated with self-reported health-related quality of life (HRQOL) in patients from a US multiethnic SLE cohort. Lupus. 2007;16:195–196
  130. Calvo-Alen J, Alarcón GS, Campbell R, Fernandez M, Reveille JD, Cooper GS. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology (Oxford). 2005;44:1186–1189
  131. Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus. 2003;12:280–286
  132. Sanchez ML, Costenbader KH, Karlson EW, Alarcón GS, Wolfe F. Is it possible to ascertain damage in lupus utilizing a self-reported nquestionnaire? (Preliminary data on the Lupus Damage Index Questionnaire (LDIQ)). Arthritis Rheum. 2008;(in press)

PII: S0049-0172(08)00197-2

doi: 10.1016/j.semarthrit.2008.10.007

Seminars in Arthritis and Rheumatism
Volume 39, Issue 4 , Pages 257-268 , February 2010

Article Tools

* Image Usage & Resolution